Trump backs RFK Jr's debunked Tylenol-autism claim
Former President Donald Trump has publicly supported Robert F. Kennedy Jr's unsubstantiated theory linking Tylenol use during pregnancy to autism, drawing sharp criticism from medical experts.
Category : Pharmaceuticals
Weight Loss Drugs May Alter Pancreas Cells: Study
New research reveals that GLP-1 based weight loss medications like Ozempic may cause unforeseen changes to pancreas cells, raising important safety questions for millions of users worldwide.
UK Experts Debunk Paracetamol Fearmongering
Leading UK medical professionals challenge sensationalised claims about paracetamol risks, arguing they could prevent vulnerable people from seeking essential pain relief.
Tylenol Maker Responds to Autism Lawsuit Arguments
Johnson & Johnson faces hundreds of lawsuits alleging a link between prenatal Tylenol use and autism or ADHD, as the Trump administration's legal arguments resurface.
Pfizer Revives Weight-Loss Pill to Challenge Obesity Drug Leaders
Pfizer announces a surprising turnaround in its weight-loss strategy, advancing two new daily pills in a heated battle for the lucrative obesity drug market dominated by injectables.
The Real-Life 'Candy Man' Doctor Who Hooked a Generation
The shocking true story of Dr. Robert Weitzel, the Utah paediatrician who prescribed millions of pills to teenagers in the 1970s, earning him the infamous nickname and sparking a national drug crisis.
Wegovy Weight Loss Pill Shows 'Substantial' Results in UK
A major UK trial reveals the new semaglutide pill, a potential game-changer in obesity treatment, leads to significant weight loss, offering a powerful alternative to injections.
New Weight Loss Jab Helps Shed Over 20% Body Weight
A landmark UK study reveals the new weight loss injection Tirzepatide is significantly more effective than existing treatments, helping patients lose over 20% of their body weight and offering new hope in the fight against obesity.
New Weight Loss Pill Rivals Wegovy in Groundbreaking Trial
A new oral weight loss drug, Orforglipron, shows staggering results in a major clinical trial, offering a powerful and convenient alternative to injectable treatments for obesity.
New Weight Loss Pill 'More Powerful Than Ozempic'
A revolutionary new weight loss pill, Survodutide, is making waves in medical trials, with manufacturers boasting it could be twice as effective as blockbuster drugs like Ozempic and Wegovy.
New Weight Loss Pill Cuts Body Weight By 20%
Breakthrough obesity drug Orforglipron shows unprecedented results in clinical trials, reducing body weight by a fifth and offering new hope for millions struggling with weight management in the UK.
New Weight Loss Pill Shows Promise in UK Trial
A groundbreaking new oral weight loss drug, Orforglipron, could rival Wegovy injections after a UK study showed participants lost over 10% of their body weight. Discover the potential game-changer for obesity treatment.
AstraZeneca shifts cancer drug production from UK to Ireland
Pharmaceutical giant Merck to manufacture flagship cancer drug Lynparza at new €1 billion Irish facility, dealing significant blow to UK's life sciences sector and raising fresh post-Brexit trade concerns.
FDA Condemns Trump's 'Reckless' Ozempic Endorsement
US health officials and medical bodies issue a stern warning after Donald Trump's controversial promotion of diabetes drugs for weight loss, citing severe health risks and misuse.
Trump Threatens NHS Drug Pricing: UK Faces US Medicine Costs
Exclusive analysis reveals how a potential Trump presidency could jeopardise Britain's NHS medicine pricing, forcing UK patients to pay US-style pharmaceutical costs.
Big Pharma's Billion-Pound Bet on Post-Trump UK
Major pharmaceutical giants AstraZeneca, MSD (Merck), and Eli Lilly announce massive new investments in UK research and manufacturing, signalling a major vote of confidence in the British life sciences sector following the US election result.
New Higher Dose Wegovy Jab Approved for UK Weight Loss
The NHS receives a powerful new weapon in the fight against obesity as medical regulators approve a higher 2.4mg dose of Wegovy, proven to help patients shed significantly more weight.
Revolutionary Eye Drops Could Replace Reading Glasses
Groundbreaking new eye drops developed by scientists could soon free millions from the hassle of reading glasses, offering a simple solution for age-related vision decline.
TikTok's Dangerous 'Skinny Jab' Trend Exposed
Exclusive investigation reveals the alarming trend of unregulated weight-loss jabs like Retatrutide being promoted on TikTok, posing severe health risks to UK users desperate for quick fixes.
Sanofi CEO: UK is 'terrible place' for medicines
Sanofi executive warns of UK's worsening medicines access crisis, citing post-Brexit regulations, NICE hurdles, and a pricing system that deters investment and innovation.
MSD to create 125+ new R&D jobs in London expansion
Pharmaceutical giant MSD, known as Merck in the US, is significantly expanding its UK presence with a new state-of-the-art research hub in London, generating over 125 new high-skilled jobs and reinforcing the city's status as a global life sciences leader
UK signs deal for Merck's groundbreaking Covid-19 pill
The UK government has secured 250,000 courses of Merck's molnupiravir, an innovative antiviral pill shown to halve hospitalisations in a major scientific breakthrough.
Pharma Giant Cuts 9,000 Jobs in Major Restructure
A major pharmaceutical multinational has announced a drastic cost-cutting plan, putting 9,000 roles at risk globally. The move signals deepening turmoil within the industry, raising concerns for the UK's strategic life sciences sector.
Mounjaro KwikPens launch without price reduction
Exclusive: Diabetes and weight loss patients face financial strain as Eli Lilly's new Mounjaro KwikPens hit the market without the anticipated price reduction, maintaining a premium cost for the identical medication.
Novo Nordisk's £90m UK Expansion for Ozempic Production
Danish pharmaceutical giant Novo Nordisk announces major £90 million expansion at its Gatwick facility to meet soaring global demand for its blockbuster diabetes and weight-loss drugs, Ozempic and Wegovy, creating new high-skilled jobs.
Wegovy Jab Sends Novo Nordisk Shares Soaring Past £400bn
Danish pharmaceutical giant Novo Nordisk's market value skyrockets past £400bn, briefly eclipsing the entire Danish economy, on the back of soaring demand for its blockbuster weight-loss drug, Wegovy.
Germany seizes illegal Wegovy shipment in Frankfurt
German authorities have confiscated thousands of doses of the in-demand weight-loss medication Wegovy from a Frankfurt wholesaler, citing illegal parallel imports from outside the EU and improper storage conditions.
Novo Nordisk cuts 9,000 jobs amid Ozempic competition
Danish pharmaceutical giant Novo Nordisk announces major restructuring, cutting 9,000 jobs globally. The move comes as competition intensifies in the lucrative weight-loss and diabetes drug market, challenging its blockbuster medications Ozempic and Wegov
Mounjaro users hit by smaller pen, dose removal & 170% price hike
Eli Lilly deals a major blow to UK Mounjaro users, announcing a smaller KwikPen, the removal of a key 12.5mg dose, and a staggering 170% price increase, sparking outrage and access fears.
Mounjaro Shortage: Diabetics Priced Out of Miracle Drug
Exclusive: Desperate UK diabetics face a devastating health crisis as they are cut off from the 'miracle' weight-loss drug Mounjaro (tirzepatide) due to soaring costs and an NHS postcode lottery, with patients fearing for their lives.
Page 8 of 12